Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease

Astellas

Status: Completed

Conditions: Chronic Kidney Disease

Treatments: Drug: Bixalomer

Study type: Observational

Funder types: Industry

Identifiers

NCT02805348

1585-MA-3052

Details and patient eligibility

About

The objective of this study is to assess the long-term safety and efficacy of bixalomer under post-marketed setting.

Enrollment: 144 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients with pre-dialysis chronic kidney disease complicated by hyperphosphatemia who used bixalomer for the first time

Trial design

144 participants in 1 patient group

Chronic kidney disease

Description:

Patients with pre-dialysis chronic kidney disease complicated by hyperphosphatemia who used bixalomer for the first time.

Treatment:

Drug: Bixalomer